Mead Johnson Nutrition Company (MJN)

NYSE

Currency in USD

89.98

0.00(0.00%)

Closed14/06

Fair Value

Day's Range

89.97

90.00

52 wk Range

0.00

90.00

MJN Income Statement

Featured here, the Income Statement (earnings report) for Mead Johnson Nutrition Company, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

Total Revenues

3,901.3

4,200.7

4,409.3

4,071.3

3,742.7

Total Revenues Growth

+6.1%

+7.67%

+4.97%

-7.67%

-8.07%

Cost Of Revenues

1,503.8

1,528.5

1,700.6

1,445

1,341

Gross Profit

2,397.5

2,672.2

2,708.7

2,626.3

2,401.7

Gross Profit Growth

+3.58%

+11.46%

+1.37%

-3.04%

-8.55%

Gross Profit Margin %

61.45%

63.61%

61.43%

64.51%

64.17%

Other Operating Expenses, Total

1,537.5

1,652.4

1,732.7

1,639.7

1,490.8

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+6.31%	+7.47%	+4.86%	-5.37%	-9.08%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	100.1	100.2	115.1	108.4	97.4
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,437.4	1,548.6	1,617.6	1,532	1,393.5
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	3.6	-	-0.7	-0.1

Operating Income

860

1,019.8

976

986.6

910.9

Operating Income Growth

-0.97%

+18.58%

-4.29%

+1.09%

-7.67%

EBIT Margin %

22.04%

24.28%

22.14%

24.23%

24.34%

Net Interest Expenses

-65

-50.6

-60.3

-65

-105.4

Net Interest Expenses Growth

-24.52%

+22.15%

-19.17%

-7.79%

-62.15%

Interest Expense, Total

-70.9

-59.2

-69.9

-74.6

-118.7

Interest And Investment Income

5.9

8.6

9.6

9.6

13.3

Other Non Operating Expenses, Total

-3.3

-9.3

5.6

-4

14.1

EBT, Excl. Unusual Items

791.7

959.9

921.3

917.6

819.6

Gain (Loss) On Sale Of Assets

6.5

-

-

-9

-

Other Unusual Items, Total

-27.9

-35.6

2.7

-18.6

-77.1

EBT, Incl. Unusual Items

770.3

924.3

928

871.2

713.3

EBT, Incl. Unusual Items Growth

+6.7%

+19.99%

+0.4%

-6.12%

-18.12%

EBT, Incl. Unusual Items Margin

19.74%

22%

21.05%

21.4%

19.06%

Income Tax Expense

182

235.1

199.2

215.9

164

Net Income to Company

588.3

689.2

728.8

655.3

549.3

Minority Interest

-7.9

-5.4

-9

-1.8

-4.4

Net Income

580.4

683.8

719.8

653.5

544.9

Net Income Growth

+14.14%

+17.82%

+5.26%

-9.21%

-16.62%

Net Income Margin %

14.88%

16.28%

16.32%

16.05%

14.56%

Preferred Dividend and Other Adjustments

1.3

1.3

1.3

1.7

2.2

Net Income to Common Excl. Extra Items

579.1

682.5

718.5

651.8

542.7

Basic EPS - Continuing Operations

2.84

3.37

3.56

3.28

2.93

Basic EPS - Continuing Operations Growth

+14.59%

+18.55%

+5.43%

-7.87%

-10.68%

Diluted EPS - Continuing Operations

2.83

3.36

3.54

3.27

2.92

Diluted EPS - Continuing Operations Growth

+14.57%

+18.73%

+5.36%

-7.63%

-10.7%

Basic Weighted Average Shares Outstanding

203.6

202.4

202.1

199

185.5

Diluted Weighted Average Shares Outstanding

204.3

203.1

202.7

199.4

185.8

Dividend Per Share

1.2

1.36

1.5

1.65

1.65

Dividend Per Share Growth

+15.38%

+13.33%

+10.29%

+10%

0%

EBITDA

936.9

1,102.9

1,067.6

1,085.7

1,010.5

EBITDA Growth

-0.72%

+17.72%

-3.2%

+1.7%

-6.93%

EBITDA Margin %

24.02%

26.26%

24.21%

26.67%

27%

EBIT